Market Overview

UPDATE: Mizuho Securities USA Initiates Coverage On NewLink Genetics Corp On Emerging Market Pure Play

Share:

In a report published Friday, Mizuho Securities USA analyst Peter Lawson initiated coverage on NewLink Genetics Corp (NASDAQ: NLNK) with a Buy rating and $50.00 price target.

In the report, Mizuho Securities USA noted, “We are initiating coverage of shares of NewLink Genetics with a Buy rating and a price target of $50. NewLink is a pure play on the rapidly emerging immuno-oncology market, with substantial near-term catalysts that start 1Q15, a pipeline of 7 therapeutics across multiple settings using both small molecule and biological drugs and two late Phase III trials.”

NewLink Genetics Corp closed on Thursday at $26.68.

Latest Ratings for NLNK

DateFirmActionFromTo
Feb 2019MaintainsNeutralNeutral
Jan 2019DowngradesNeutralUnderperform
Nov 2018MaintainsNeutralNeutral

View More Analyst Ratings for NLNK
View the Latest Analyst Ratings

Posted-In: Mizuho Securities USA Peter LawsonAnalyst Color Initiation Analyst Ratings

 

Related Articles (NLNK)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
REALDA DavidsonInitiates Coverage On22.0
RVLVDA DavidsonInitiates Coverage On19.0
SFIXDA DavidsonInitiates Coverage On27.0
CONNKeyBancDowngrades
PENNJP MorganMaintains29.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Morning Market Movers

UPDATE: Wunderlich Initiates Coverage On Perry Ellis International, Inc.